Flubromazolam’s position in scientific trials is proscribed because of its classification like a designer drug. Having said that, its effects have already been reversed through the benzodiazepine antagonist flumazenil in pharmacokinetic scientific tests, furnishing insights into its scientific implications and crisis management of overdoses.Savi